VIBE Share Price Performance

VIBE Community Fair Values

Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor
The Future of Drug Testing? Fingerprint Tech Shows Serious Promise
Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
40.3% undervalued intrinsic discount
59.20%
Revenue growth p.a.
7users have liked this narrative
0users have commented on this narrative
38users have followed this narrative
15 days ago author updated this narrative
Your Fair Value
CA$
Current Price
CA$0.09587.5% undervalued intrinsic discount
Growth estimate over
Annual revenue growth rate
%/yr
Decrease
Increase
Advanced

View all narratives

Recent VIBE News & Updates

Improved Revenues Required Before Vibe Growth Corporation (CSE:VIBE) Stock's 75% Jump Looks Justified

Nov 22

There's No Escaping Vibe Growth Corporation's (CSE:VIBE) Muted Revenues Despite A 31% Share Price Rise

Sep 27

Vibe Growth Corporation Competitors

U.S. Market Performance

0.3%

5.6%

10.4%

1.6%

Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. As for the longer term, the market has risen 10% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›

Vibe Growth Stock Price

VIBE Share Price Performance

VIBE Community Fair Values

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Recent VIBE News & Updates

First quarter 2025 earnings released: US$0.022 loss per share (vs US$0.067 loss in 1Q 2024)

New major risk - Negative shareholders equity

Insufficient new directors

Third quarter 2024 earnings released: US$0.009 loss per share (vs US$0.12 loss in 3Q 2023)

Improved Revenues Required Before Vibe Growth Corporation (CSE:VIBE) Stock's 75% Jump Looks Justified

There's No Escaping Vibe Growth Corporation's (CSE:VIBE) Muted Revenues Despite A 31% Share Price Rise

Second quarter 2024 earnings released: US$0.04 loss per share (vs US$0.13 loss in 2Q 2023)

First quarter 2024 earnings released: US$0.067 loss per share (vs US$0.10 loss in 1Q 2023)

Vibe Growth Corporation Competitors

Jack Nathan Medical

Tevano Systems Holdings

Ventripoint Diagnostics

Premier Health of America

🎢 Asia’s 2025 Rollercoaster: From Trade Turmoil to Market Rebounds

🚀 Finding Moonshots in the Space Race